Cargando…
Pharmacodynamic modelling of resistance to epidermal growth factor receptor inhibition in brain metastasis mouse models
PURPOSE: Epidermal growth factor receptor (EGFR) is thought to play a role in the regulation of cell proliferation; with its activation stimulating tumour growth. EGFR inhibitors have shown promise in the treatment of cancer, particularly in non-small cell lung cancer, however, resistance is observe...
Autores principales: | Martin, Emma C., Aarons, Leon, Yates, James W. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132866/ https://www.ncbi.nlm.nih.gov/pubmed/30054711 http://dx.doi.org/10.1007/s00280-018-3630-8 |
Ejemplares similares
-
Inhibition of Anti-Inflammatory Macrophage Phenotype Reduces Tumour Growth in Mouse Models of Brain Metastasis
por: Economopoulos, Vasiliki, et al.
Publicado: (2022) -
Mouse Syngeneic Melanoma Model with Human Epidermal Growth Factor Receptor Expression
por: Slastnikova, Tatiana A., et al.
Publicado: (2022) -
Clinical Pharmacokinetics and Pharmacodynamics of the Epidermal Growth Factor Receptor Inhibitor Panitumumab in the Treatment of Colorectal Cancer
por: Ketzer, Sander, et al.
Publicado: (2017) -
Parameter Identifiability of Fundamental Pharmacodynamic Models
por: Janzén, David L. I., et al.
Publicado: (2016) -
WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models
por: Conage-Pough, Jason E, et al.
Publicado: (2023)